133 related articles for article (PubMed ID: 28859044)
21. Preoperative chemotherapy with doxorubicin in Wilms tumor.
Küpeli S; Bilici S
J Pediatr Hematol Oncol; 2012 Apr; 34(3):e106-9. PubMed ID: 22146531
[TBL] [Abstract][Full Text] [Related]
22. Outcomes based on histopathologic response to preoperative chemotherapy in children with bilateral Wilms tumor: A prospective study (COG AREN0534).
Chintagumpala MM; Perlman EJ; Tornwall B; Chi YY; Kim Y; Hoffer FA; Kalapurakal JA; Warwick AB; Shamberger RC; Khanna G; Hamilton TE; Gow KW; Paulino AC; Gratias EJ; Mullen EA; Geller JI; Fernandez CV; Ritchey ML; Grundy PE; Dome JS; Ehrlich PF
Cancer; 2022 Jul; 128(13):2493-2503. PubMed ID: 35383900
[TBL] [Abstract][Full Text] [Related]
23. Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study.
Daw NC; Chi YY; Kalapurakal JA; Kim Y; Hoffer FA; Geller JI; Perlman EJ; Ehrlich PF; Mullen EA; Warwick AB; Grundy PE; Paulino AC; Gratias E; Ward D; Anderson JR; Khanna G; Tornwall B; Fernandez CV; Dome JS;
J Clin Oncol; 2020 May; 38(14):1558-1568. PubMed ID: 32134700
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of effect of preoperative chemotherapy on Wilms' tumor histopathology.
Taskinen S; Lohi J; Koskenvuo M; Taskinen M
J Pediatr Surg; 2018 Aug; 53(8):1611-1614. PubMed ID: 29074135
[TBL] [Abstract][Full Text] [Related]
25. [A case report of adult Wilms' tumor].
Sugimura Y; Yanagawa M; Tochigi H; Sakurai M; Hioki T; Hayashi N; Tajima K; Kawamura J
Hinyokika Kiyo; 1989 Jul; 35(7):1173-7. PubMed ID: 2552780
[TBL] [Abstract][Full Text] [Related]
26. [Cover image. Bilateral nephroblastomatosis with secondary Wilms tumor manifestations].
Horger MS; Fendel A
Rofo; 2003 Apr; 175(4):453-4. PubMed ID: 12765189
[No Abstract] [Full Text] [Related]
27. Management decisions in children with nephroblastomatosis.
Prasil P; Laberge JM; Bond M; Bernstein M; Pippi-Salle JL; Bernard C; Patenaude Y
Med Pediatr Oncol; 2000 Oct; 35(4):429-32; discussion 433. PubMed ID: 11025476
[No Abstract] [Full Text] [Related]
28. Near complete resolution of refractory, relapsed, metastatic Wilms' tumour in an adolescent with bevacizumab.
Kumar S; Burney IA; Al-Moundhri MS
J Coll Physicians Surg Pak; 2014 Mar; 24 Suppl 1():S71-2. PubMed ID: 24718015
[TBL] [Abstract][Full Text] [Related]
29. Irinotecan for relapsed Wilms tumor in pediatric patients: SIOP experience and review of the literature-A report from the SIOP Renal Tumor Study Group.
Hol JA; van den Heuvel-Eibrink MM; Graf N; Pritchard-Jones K; Brok J; van Tinteren H; Howell L; Verschuur A; Bergeron C; Kager L; Catania S; Spreafico F; Mavinkurve-Groothuis AMC
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 29077255
[TBL] [Abstract][Full Text] [Related]
30. Brain metastasis of Wilms tumor with diffuse anaplasia and complex cytogenetic phenotype in a child with neurofibromatosis Type 1.
Shvartsbeyn M; Bassani L; Mikolaenko I; Wisoff JH
J Neurosurg Pediatr; 2011 Oct; 8(4):353-6. PubMed ID: 21961578
[TBL] [Abstract][Full Text] [Related]
31. Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor Studies.
Breslow NE; Ou SS; Beckwith JB; Haase GM; Kalapurakal JA; Ritchey ML; Shamberger RC; Thomas PR; D'Angio GJ; Green DM
Cancer; 2004 Sep; 101(5):1072-80. PubMed ID: 15329918
[TBL] [Abstract][Full Text] [Related]
32. Anaplastic nephrogenic rest.
Argani P; Collins MH
Am J Surg Pathol; 2006 Oct; 30(10):1339-41. PubMed ID: 17001170
[No Abstract] [Full Text] [Related]
33. Response to letter commenting on "Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG)".
; van den Heuvel-Eibrink MM; Pritchard-Jones K; van Tinteren H; Graf N
Eur J Cancer; 2015 May; 51(8):995-6. PubMed ID: 25840668
[No Abstract] [Full Text] [Related]
34. The use of preoperative chemotherapy in Wilms' tumor with contained retroperitoneal rupture.
Ehrlich PF
J Pediatr Surg; 2008 Feb; 43(2):415-6; author reply 416-7. PubMed ID: 18280305
[No Abstract] [Full Text] [Related]
35. Microscopic neoplastic thrombosis in localised nephroblastoma: does it influence outcome?
De Ioris MA; Aloi I; Camassei FD; Ravà L; Boldrini R; De Sio L; De Laurentis C; Castellano A; Crocoli A; Locatelli F; Jenkner A; Inserra A
Eur J Cancer; 2011 Mar; 47(5):718-23. PubMed ID: 21129949
[TBL] [Abstract][Full Text] [Related]
36. Outcome of two patients with bilateral nephroblastomatosis/Wilms tumour treated with an add-on 13-cis retinoic acid therapy - Case report.
Friesenbichler W; Krizmanich W; Lakatos K; Attarbaschi A; Dworzak M; Amann G; Furtwängler R; Graf N; Kager L
Pediatr Hematol Oncol; 2018 Apr; 35(3):218-224. PubMed ID: 30260265
[TBL] [Abstract][Full Text] [Related]
37. [The role of chemotherapy in treatment of nephroblastoma in children. Report of the Polish Pediatric Group re. treatments of solid tumors].
Sawicz-Birkowska K; Czernik J; Godziński J; Bagłaj M; Balcerska A; Daszkiewicz P; Dembowska B; Drozyńska U; Kantorowicz S; Kazanowska B; Kaski K; Madziara W; Perek D; Skotnicka G; Rokicka-Milewska R; Radwańska U; Wysocki M; Apoznański W
Pol Merkur Lekarski; 1998 Mar; 4(21):134-6. PubMed ID: 9640063
[TBL] [Abstract][Full Text] [Related]
38. Wilms' tumor after treatment.
Brisigotti M; Cozzutto C; Fabbretti G; Caliendo L; Haupt R; Cornaglia-Ferraris P; Callea F
Pediatr Pathol; 1992; 12(3):397-406. PubMed ID: 1329055
[TBL] [Abstract][Full Text] [Related]
39. Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: a report from the National Wilms' Tumor Study Group.
Green DM; Breslow NE; Beckwith JB; Finklestein JZ; Grundy P; Thomas PR; Kim T; Shochat S; Haase G; Ritchey M; Kelalis P; D'Angio GJ
J Clin Oncol; 1998 Dec; 16(12):3744-51. PubMed ID: 9850017
[TBL] [Abstract][Full Text] [Related]
40. A case of mixed adult Wilms' tumour and angiosarcoma responsive to carboplatin, etoposide and vincristine (CEO).
Yau T; Leong CH; Chan WK; Chan JK; Liang RH; Epstein RJ
Cancer Chemother Pharmacol; 2008 Apr; 61(4):717-20. PubMed ID: 17571263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
